SCA Pharmaceuticals recalls Ketamine 50 mg/5mL in 0.9% Sodium Chloride Injection (10 mg/mL), CII, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuti
Recalled January 13, 2021 · FDA recall D-0217-2021 · SCA Pharmaceuticals
Hazard
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit · FDA Class II
Units
9942 syringes
Sold at
Product was distributed to hospitals nationwide.
Description
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Product
Ketamine 50 mg/5mL in 0.9% Sodium Chloride Injection (10 mg/mL), CII, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004043009
Manufacturer(s)
SCA Pharmaceuticals
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →